Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 313-324 of 23,847
Drug study icon
RecruitingNCT06569394

Cannabidiol in Young Adult Cannabis Users

This study is recruiting in the United States. It is testing cannabidiol for Addiction.

In Aurora
AddictionDrugA study involving a medication or substance.From 18 Years to 25 Years
Countries
United States
Sponsor
University of Colorado, Denver
Condition
Addiction
Drug study icon
RecruitingNCT07053345

Esketamine Nasal Spray for treatment-resistant depression

This study is recruiting in South Korea. It is testing esketamine Nasal Spray for treatment-resistant depression.

Multiple locations, including Goyang Si Gyeonggi Do
DepressionDrugFrom 18 Years to 64 Years
Countries
South Korea
Sponsor
Janssen Korea, Ltd., Korea
Condition
Depression
Other study type icon
RecruitingISRCTN81388388

Home-use brain stimulation to treat Depression in bipolarity

This study is recruiting in the United Kingdom. It is testing home-use brain stimulation to treat Depression for depression in bipolarity.

In London
Bipolarity, DepressionOtherFrom 18 Years to 110 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Bipolarity, Depression
Other study type icon
RecruitingISRCTN13567753

Interventions for Suicide prevention in men's prisons

This study is recruiting in the United Kingdom. It is testing interventions for Suicide prevention.

In United Kingdom
SuicidalityOtherOver 18 Years
Countries
United Kingdom
Sponsor
Lancashire and South Cumbria NHS Foundation Trust
Condition
Suicidality
Biological study icon
RecruitingNCT03588975

MACI for OCD

This study is recruiting in the United States. It is testing MACI for OCD.

Multiple locations, including Palo Alto
OCDBiologicalFrom 10 Years to 17 Years
Countries
United States
Sponsor
Vericel Corporation
Condition
OCD
Drug study icon
RecruitingNCT07323784

NTX-1472 in Social Anxiety Disorder

This study is recruiting in the United States. It is testing NTX-1472 for anxiety.

Multiple locations, including Encino
AnxietyDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Newleos Therapeutics, Inc.
Condition
Anxiety
Drug study icon
RecruitingNCT07263191

Olanzapine in people with Bipolarity.

This study is recruiting in South Korea. It is testing olanzapine for Bipolarity.

In Seongnam
BipolarityDrugOver 19 Years
Countries
South Korea
Sponsor
Boryung Pharmaceutical Co., Ltd
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.